The Combination of Gefitinib With ATRA and ATO Induces Myeloid Differentiation in Acute Promyelocytic Leukemia Resistant Cells.

MLA

de Almeida, Luciana Yamamoto, et al. “The Combination of Gefitinib With ATRA and ATO Induces Myeloid Differentiation in Acute Promyelocytic Leukemia Resistant Cells.” Frontiers in Oncology, vol. 11, Sept. 2021, p. 686445. EBSCOhost, https://doi.org/10.3389/fonc.2021.686445.

APA

de Almeida, L. Y., Pereira-Martins, D. A., Weinhäuser, I., Ortiz, C., Cândido, L. A., Lange, A. P., De Abreu, N. F., Mendonza, S. E. S., de Deus Wagatsuma, V. M., Do Nascimento, M. C., Paiva, H. H., Alves-Paiva, R. M., Bonaldo, C. C. O. M., Nascimento, D. C., Alves-Filho, J. C., Scheucher, P. S., Lima, A. S. G., Schuringa, J. J., Ammantuna, E., … Rego, E. M. (2021). The Combination of Gefitinib With ATRA and ATO Induces Myeloid Differentiation in Acute Promyelocytic Leukemia Resistant Cells. Frontiers in Oncology, 11, 686445. https://doi.org/10.3389/fonc.2021.686445

Chicago

de Almeida, Luciana Yamamoto, Diego A Pereira-Martins, Isabel Weinhäuser, César Ortiz, Larissa A Cândido, Ana Paula Lange, Nayara F De Abreu, et al. 2021. “The Combination of Gefitinib With ATRA and ATO Induces Myeloid Differentiation in Acute Promyelocytic Leukemia Resistant Cells.” Frontiers in Oncology 11 (September): 686445. doi:10.3389/fonc.2021.686445.